PHIO - Phio Pharmaceuticals Corp.

QQQ $ 634.08 $ 0.00 (0 %)

DIA $ 475.53 $ 0.00 (0 %)

SPY $ 685.00 $ 0.00 (0 %)

TLT $ 90.28 $ 0.00 (0 %)

GLD $ 368.54 $ 0.00 (0 %)

Previous Close

$ 2.06

Open

$ 2.08

Bid

$ 2.00 x 265

Ask

$ 2.50 x 100

Day's Range

-- - --

52 Week Range

$ 0.97 - $ 9.79

Volume

62,027

Average Volume

Market Cap

11.8M

Beta (5Y Monthly)

$ 1.49

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-14-2025	06-30-2025	10-Q
2	05-15-2025	03-31-2025	10-Q
3	03-31-2025	12-31-2024	10-K
4	11-14-2024	09-30-2024	10-Q
5	08-14-2024	06-30-2024	10-Q
6	05-09-2024	03-31-2024	10-Q
7	04-01-2024	12-31-2023	10-K
8	11-09-2023	09-30-2023	10-Q
9	08-10-2023	06-30-2023	10-Q
10	05-11-2023	03-31-2023	10-Q
11	03-22-2023	12-31-2022	10-K
12	11-10-2022	09-30-2022	10-Q
13	08-11-2022	06-30-2022	10-Q
14	05-12-2022	03-31-2022	10-Q
15	03-22-2022	12-31-2021	10-K
16	11-10-2021	09-30-2021	10-Q
17	08-12-2021	06-30-2021	10-Q
18	05-13-2021	03-31-2021	10-Q
19	03-25-2021	12-31-2020	10-K
20	11-10-2020	09-30-2020	10-Q
21	08-12-2020	06-30-2020	10-Q
22	05-12-2020	03-31-2020	10-Q
23	03-26-2020	12-31-2019	10-K
24	11-12-2019	09-30-2019	10-Q
25	08-12-2019	06-30-2019	10-Q
26	05-14-2019	03-31-2019	10-Q
27	03-27-2019	12-31-2018	10-K
28	11-14-2018	09-30-2018	10-Q
29	08-14-2018	06-30-2018	10-Q
30	05-10-2018	03-31-2018	10-Q
31	03-26-2018	12-31-2017	10-K
32	11-08-2017	09-30-2017	10-Q
33	08-10-2017	06-30-2017	10-Q
34	05-11-2017	03-31-2017	10-Q
35	03-30-2017	12-31-2016	10-K
36	11-10-2016	09-30-2016	10-Q
37	08-11-2016	06-30-2016	10-Q
38	05-12-2016	03-31-2016	10-Q
39	03-30-2016	12-31-2015	10-K
40	11-12-2015	09-30-2015	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Phio Pharma To Present Update On Proprieta...
09/23/2025 11:50:15

Phio Pharmaceuticals Corp. (NASDAQ:PHIO) is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its ...

Phio Pharma To Present PH-762 INTASYL siRN...
09/18/2025 11:48:35

Key updates to include advances made in the on-going clinical trial for INTASYL siRNA lead product candidate PH-762King of Prus...

Phio Pharmaceuticals to Discuss Strategy f...
09/03/2025 11:51:41

Phio Pharmaceuticals Corp. (NASDAQ:PHIO) is a clinical-stage biopharmaceutical company developing therapeutics using its propri...

Phio Pharmaceuticals Has Been Issued Canad...
09/02/2025 19:58:46

https://www.ic.gc.ca/opic-cipo/cpd/eng/patent/3027780/summary.html

HC Wainwright & Co. Reiterates Buy on Phio...
08/15/2025 11:17:14

HC Wainwright & Co. analyst Matthew Keller reiterates Phio Pharma (NASDAQ:PHIO) with a Buy and maintains $14 price target.

Phio Pharma Q2 EPS $(0.45) Misses $(0.36) ...
08/14/2025 20:19:55

Phio Pharma (NASDAQ:PHIO) reported quarterly losses of $(0.45) per share which missed the analyst consensus estimate of $(0.36)...

Phio Pharmaceuticals Announces $2.5M In Gr...
07/25/2025 19:07:55

Phio Pharmaceuticals Corp. (NASDAQ:PHIO), a clinical-stage siRNA biopharmaceutical company developing therapeutics using its pr...

12 Health Care Stocks Moving In Friday's I...
07/25/2025 17:07:15

Phio Pharmaceuticals Reports Complete Tumo...
07/25/2025 16:40:26

Complete Pathologic Response in patient with cutaneous squamous cell carcinomaPartial Response in Stage 4 metastatic Merkel cel...

12 Health Care Stocks Moving In Friday's P...
07/25/2025 12:08:49

Phio Pharmaceuticals Announces Comprehensi...
07/25/2025 11:47:08

HC Wainwright & Co. Reiterates Buy on Phio...
06/25/2025 14:43:29

HC Wainwright & Co. analyst Joseph Pantginis reiterates Phio Pharma (NASDAQ:PHIO) with a Buy and maintains $14 price tar...

Phio Pharmaceuticals Announced That The Sa...
06/25/2025 11:49:15

1. Phio Pharma CEO To Present New Skin Can...
06/24/2025 11:47:05

Phio Pharmaceuticals Corp. (NASDAQ:PHIO) is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its ...

12 Health Care Stocks Moving In Thursday's...
06/05/2025 17:06:23

HC Wainwright & Co. Assumes Phio Pharma at...
06/05/2025 11:11:13

HC Wainwright & Co. analyst Joseph Pantginis assumes Phio Pharma (NASDAQ:PHIO) with a Buy rating and announces Price Tar...

Phio Pharma To Present Update On Proprieta...
05/19/2025 11:50:47

Registration Link for Presentation to take place Thursday, May 22, 2025 at 10:00 AM ETMarlborough, Massachusetts--(Newsfile Cor...

Phio Pharma Q1 EPS $(0.47) Down From $(0.4...
05/15/2025 20:46:10

Phio Pharma (NASDAQ:PHIO) reported quarterly losses of $(0.47) per share. This is a 14.63 percent decrease over losses of $(0.4...

12 Health Care Stocks Moving In Wednesday'...
05/07/2025 17:06:24

Phio Pharma Announces Pathology Results In...
05/07/2025 11:47:29

Complete Pathologic Response reported in 2 patients in the Third Cohort with cutaneous squamous cell carcinoma, complementing r...